Navigation Links
Vascular Health Sciences Introduces Executive and Advisory Team
Date:12/23/2012

Salt Lake City, UT (PRWEB) December 23, 2012

Vascular Health Sciences, in an effort to help its customers and stakeholders get to know the company’s executive team, has published a “Meet the Team” page on VascularHealthSciences.com with biographical and historical background information.

The page introduces Co-Founder and Chief Executive Officer Bob Long; Co-Founder and Chief Operating Officer David Daniels; Co-Founder and Senior Vice President of Product Development Bruce Bouche, DC; Chief Science Officer Nathalie Chevreau, PhD, RD; and the advisory team, which includes Medical Advisor Derrick DeSilva Jr., MD; and Science Advisor Hans Vink, Ph.D.

About Vascular Health Sciences
Founded in 2010, Vascular Health Sciences explores technologies, develops products and disseminates information to increase awareness and promote the proper care of the endothelial glycocalyx. Vascular Health Sciences is committed to increasing awareness of the glycocalyx and its role in vascular health, and to providing products supporting the care of this essential system. For more information, visit VascularHealthSciences.com.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10257189.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Study shows heart calcium scan predictive of diabetes-related death from cardiovascular disease
2. High hormone levels put young black males at risk for cardiovascular disease
3. Pure Cocoa Powder, the Key Ingredient in Dark Chocolate and Found in Diabetes Support Supplements has been Clinically Proven to Reduce Cardiovascular Risk
4. Frequency of alcohol consumption and cardiovascular risk factors
5. Protein tug of war points toward better therapies for cardiovascular disease
6. Timing of first menstrual cycle may be predictor of cardiovascular disease risk in women
7. Controlling vascular disease may be key to reducing prevalence of Alzheimers disease
8. US Hispanics at high risk for cardiovascular disease
9. $1.8 million grant supports investigation of psoriasis link to cardiovascular disease
10. Cardiovascular disease community calls for tougher targets to curb global risk
11. OSA increases cardiovascular mortality in the elderly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set ... one video to the next without having to set a single keyframe in ... to enhance your video production. , TransDark features dynamic transitions that momentarily splits the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... An April 24th article on ... stunning 180 pounds with the help of a weight loss surgery. The woman, declaring “I ... skin that have been left following her dramatic weight loss. Dr. Feiz & Associates notes ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Beginning in 2017, ... their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure that ... the formula in the following ways:, , Removal of the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: